Hualan Biological Engineering Dirección

Dirección controles de criterios 3/4

El CEO de Hualan Biological Engineering's es Bei Fan, nombrado en Apr 2022, tiene una permanencia de 2.08 años. posee directamente un 0.14% de las acciones de la empresa, con un valor de CN¥51.63M. La antigüedad media del equipo directivo y de la junta directiva es de 2.1 años y 4.6 años, respectivamente.

Información clave

Bei Fan

Chief Executive Officer (CEO)

n/a

Compensación total

Porcentaje del salario del CEO	n/a
Permanencia del CEO	2.4yrs
Participación del CEO	0.1%
Permanencia media de la dirección	2.4yrs
Promedio de permanencia en la Junta Directiva	4.9yrs

Actualizaciones recientes de la dirección

Recent updates

Why Investors Shouldn't Be Surprised By Hualan Biological Engineering Inc.'s (SZSE:002007) Low P/E

Aug 22

Hualan Biological Engineering Inc. (SZSE:002007) Shares Could Be 37% Below Their Intrinsic Value Estimate

Jun 26

Hualan Biological Engineering's (SZSE:002007) Dividend Will Be CN¥0.30

Jun 09

These 4 Measures Indicate That Hualan Biological Engineering (SZSE:002007) Is Using Debt Safely

Jun 07

Lacklustre Performance Is Driving Hualan Biological Engineering Inc.'s (SZSE:002007) Low P/E

May 21

Is Hualan Biological Engineering (SZSE:002007) Using Too Much Debt?

Feb 27

CEO

Bei Fan (52 yo)

2.4yrs

Permanencia

CN¥950,000

Compensación

Ms. Bei Fan serves as a General Manager of Hualan Biological Engineering Inc since April 28, 2022. Ms. Fan served as Managing Deputy General Manager of Hualan Biological Engineering Inc. She served as Secr...

Equipo directivo

Nombre	Posición	Permanencia	Compensación	Propiedad
Bei Fan	GM & Director	2.4yrs	CN¥950.00k	0.15% CN¥ 43.9m
Jun Min Xie	CFO & Secretary of the Board of Directors	11.4yrs	CN¥580.00k	0.075% CN¥ 22.5m
Bao Xian Zhang	Deputy GM & Director	no data	CN¥790.00k	0.078% CN¥ 23.3m
Xiao Wei Ma	Deputy General Manager	2.4yrs	CN¥790.00k	0.089% CN¥ 26.6m
Jun Liu	Deputy General Manager	2.4yrs	CN¥280.00k	0.015% CN¥ 4.7m
Zhengyue Chen	Deputy General Manager	3.5yrs	sin datos	0.0044% CN¥ 1.3m

2.4yrs

Permanencia media

54.5yo

Promedio de edad

Equipo directivo experimentado: El equipo directivo de 002007 se considera experimentado (2 años antigüedad media).

Miembros de la Junta

Nombre	Posición	Permanencia	Compensación	Propiedad
Bei Fan	GM & Director	17.4yrs	CN¥950.00k	0.15% CN¥ 43.9m
Bao Xian Zhang	Deputy GM & Director	16.5yrs	CN¥790.00k	0.078% CN¥ 23.3m
Yunlong Wang	Independent Director	4.4yrs	CN¥100.00k	sin datos
Kang An	Chairman of the Board of Directors	24yrs	CN¥1.20m	17.92% CN¥ 5.4b
Ruo Wen Pan	Director	2.4yrs	sin datos	0.10% CN¥ 31.1m
Zhi Guo Su	Independent Director	2.4yrs	CN¥60.00k	sin datos
Wanli Liu	Independent Director	4.4yrs	CN¥100.00k	sin datos
Wenqi An	Director	2.4yrs	sin datos	0.020% CN¥ 6.1m
Chao Yuan Ma	Supervisor	7.4yrs	sin datos	sin datos
Lin Lin Cai	Supervisor	7.4yrs	sin datos	sin datos
Yanchao Wang	Supervisor	5.4yrs	sin datos	sin datos
Wenjue An	Director	2.4yrs	sin datos	0.0022% CN¥ 657.2k

4.9yrs

Permanencia media

48.5yo

Promedio de edad

Junta con experiencia: La junta directiva de 002007 se considera experimentada (4.7 años de antigüedad promedio).

Hualan Biological Engineering Dirección

Dirección controles de criterios 3/4

Información clave

Actualizaciones recientes de la dirección

Less than half of directors are independent

Less than half of directors are independent

Hualan Biological Engineering Inc., Annual General Meeting, Apr 28, 2022

Recent updates

Investor sentiment improves as stock rises 16%

Price target decreased by 7.4% to CN¥22.68

Second quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

Why Investors Shouldn't Be Surprised By Hualan Biological Engineering Inc.'s (SZSE:002007) Low P/E

Hualan Biological Engineering Inc. to Report First Half, 2024 Results on Aug 30, 2024

Hualan Biological Engineering Inc. (SZSE:002007) Shares Could Be 37% Below Their Intrinsic Value Estimate

Hualan Biological Engineering's (SZSE:002007) Dividend Will Be CN¥0.30

Dividend of CN¥0.30 announced

Hualan Biological Engineering Inc. Announces Final Profit Distribution Plan to Be Implemented on A Shares for the Year 2023, Payable on 14 June 2024

These 4 Measures Indicate That Hualan Biological Engineering (SZSE:002007) Is Using Debt Safely

Lacklustre Performance Is Driving Hualan Biological Engineering Inc.'s (SZSE:002007) Low P/E

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

Full year 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Hualan Biological Engineering Inc. to Report Q1, 2024 Results on Apr 26, 2024

Is Hualan Biological Engineering (SZSE:002007) Using Too Much Debt?

Hualan Biological Engineering Inc. to Report Fiscal Year 2023 Results on Mar 30, 2024

Third quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Second quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Hualan Biological Engineering Inc. Announces Final Dividend on Share A for 2022, Payable on June 14, 2023

Full year 2022 earnings: EPS and revenues miss analyst expectations

Price target increased to CN¥26.17

Less than half of directors are independent

Third quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Investor sentiment improved over the past week

Second quarter 2022 earnings released: EPS: CN¥0.19 (vs CN¥0.11 in 2Q 2021)

Investor sentiment improved over the past week

Hualan Biological Engineering Inc. Announces Final Cash Dividend on A Shares for 2021, Payable on 16 June 2022

Price target decreased to CN¥27.73

Less than half of directors are independent

Investor sentiment improved over the past week

Consensus revenue estimates increase by 11%

Price target decreased to CN¥33.57

Price target decreased to CN¥33.57

Hualan Biological Engineering Inc., Annual General Meeting, Apr 28, 2022

Full year 2021 earnings: EPS and revenues miss analyst expectations

Hualan Biological Engineering Inc. Proposes Final Dividend for the Year 2021

Consensus revenue estimates fall by 32%

Price target decreased to CN¥36.80

Third quarter 2021 earnings released: EPS CN¥0.33 (vs CN¥0.25 in 3Q 2020)

Price target decreased to CN¥41.06

Investor sentiment deteriorated over the past week

Price target decreased to CN¥46.66

Second quarter 2021 earnings released: EPS CN¥0.11 (vs CN¥0.14 in 2Q 2020)

First quarter 2021 earnings released: EPS CN¥0.14 (vs CN¥0.14 in 1Q 2020)

Full year 2020 earnings released: EPS CN¥0.89 (vs CN¥0.71 in FY 2019)

Full year 2020 earnings released: EPS CN¥0.88 (vs CN¥0.70 in FY 2019)

Revenue beats expectations, earnings disappoint

New 90-day low: CN¥39.55

Hualan Biological Engineering Inc. to Report Fiscal Year 2020 Results on Mar 30, 2021

Investor sentiment improved over the past week

New 90-day high: CN¥53.98

Investor sentiment improved over the past week

New 90-day low: CN¥42.50

New 90-day low: CN¥46.08

Third quarter earnings released

Third-quarter earnings released: Revenue beats expectations, earnings disappoint

Market pulls back on stock over the past week

Earnings released

New 90-day high - CN¥59.83

CEO

Permanencia

Compensación

Equipo directivo

Permanencia media

Promedio de edad

Miembros de la Junta

Permanencia media

Promedio de edad